Long-acting bronchodilators in COPD

Chest

Volumn 133, Issue 5, 2008, Pages 1057-1058

  Sears, Malcolm R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; LONG ACTING DRUG; PLACEBO; SALMETEROL; TIOTROPIUM BROMIDE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HUMAN; PRIORITY JOURNAL;

EID: 43649090788     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-2919     Document Type: Editorial

References (12)

1. Greening AP Wind P Northfield M Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid Lancet 344 1994 219 224
2. Nelson HS Weiss ST Bleecker ER The Salmeterol Multicenter Asthma Research Trial Chest 129 2006 15 26
3. Murphy S Roberts R “Black-box” 101: how the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk J Allergy Clin Immunol 117 2006 34 39
4. Pauwels RA Lofdahl C-G Laitinen LA Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking N Engl J Med 340 1999 1948 1953
5. The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease N Engl J Med 343 2000 1902 1909
6. Donohue JF van Noord JA Bateman ED A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol Chest 122 2002 47 55
7. Aaron SD Vandemheen KL Fergusson D Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease Ann Intern Med 146 2007 545 555
8. Calverley PMA Anderson JA Celli B Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
9. Salpeter SR Buckley NS Salpeter EE Meta-analysis: anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD J Gen Intern Med 21 2006 1011 1019
10. Salpeter SR Bronchodilators in COPD: impact of β-agonists and anticholinergics on severe exacerbations and mortality Int J COPD 2 2007 11 18
11. Rodrigo GJ Nannini LJ Rodriguez-Roisin R Safety of long-acting β agonists in stable COPD: a systematic review Chest 133 2008 1079 1087
12. Qaseem A Snow V Shekelle P Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians Ann Intern Med 147 2007 633 638